Proteus mirabilis: The Enemy Within

Amiran Dzutsev1, Giorgio Trinchieri2

  • 1Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA; Leidos Biomedical Research, Inc., Frederick, MD 21702, USA.

Immunity
|April 23, 2015
PubMed

Insights

The gut must control inflammation against harmful bacteria. Proteus mirabilis triggers interleukin-1β release via the NLRP3 inflammasome pathway in inflammatory monocytes.

Area of Science:

  • Immunology
  • Microbiology
  • Gastroenterology

Background:

  • The host immune system must distinguish between commensal microbiota and potential pathogens.
  • Intestinal inflammation is crucial for eliminating pathogenic bacteria but must be tightly regulated to prevent damage from commensals or pathobionts.
  • Pathobionts, like Proteus mirabilis, can cause disease under certain conditions.

Purpose of the Study:

  • To investigate the mechanism by which the pathobiont Proteus mirabilis elicits an inflammatory response in the gut.
  • To identify the specific immune cells and molecular pathways involved in the host's response to P. mirabilis.

Main Methods:

  • The study utilized mouse models of intestinal infection.
  • Immune cell populations were analyzed using flow cytometry.
  • The role of the NLRP3 inflammasome and its downstream signaling molecules, such as interleukin-1β (IL-1β), was assessed.

Main Results:

  • Proteus mirabilis infection led to the activation of the NLRP3 inflammasome.
  • This activation resulted in the release of IL-1β from a specific subset of inflammatory monocytes (CCR2(+) Ly6C(high)).
  • The study demonstrated a direct link between P. mirabilis and inflammasome-mediated inflammation.

Conclusions:

  • The NLRP3 inflammasome is a key component in the host's response to the pathobiont Proteus mirabilis.
  • Inflammatory monocytes play a critical role in mediating IL-1β release during P. mirabilis infection.
  • Understanding these pathways is essential for developing strategies to manage intestinal inflammatory diseases.

Related Concept Videos

Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
101
Microbiota of the Urogenital Tract01:28

Microbiota of the Urogenital Tract

The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
49
Evolution of New Traits in Microbes01:24

Evolution of New Traits in Microbes

Microorganisms evolve rapidly due to their large population sizes and short generation times, often exhibiting measurable changes within days under laboratory conditions. Natural selection acts on standing genetic variation, enabling the retention and amplification of beneficial traits that confer fitness advantages in changing environments.Adaptive Pigment Regulation in RhodobacterIn Rhodobacter, a genus of purple non-sulfur bacteria, light-harvesting pigments such as bacteriochlorophyll and...
163
Overview of Protists01:27

Overview of Protists

Protists are diverse eukaryotic microorganisms that lack the specialized tissues of plants and animals and the chitinous cell walls of fungi. Their early divergence within Eukarya resulted in structural, functional, and ecological diversity. They are classified into supergroups such as Archaeplastida, Excavata, Amoebozoa, Rhizaria, Alveolata, and Stramenopiles, determined through genetic analysis and structural similarities.Structural and Functional AdaptationsProtists have various adaptations...
3.3K
Bacterial Transformation01:33

Bacterial Transformation

In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
63.8K
Bacterial Phylum Planctomycetes01:26

Bacterial Phylum Planctomycetes

Planctomycetes are a group of morphologically distinct bacteria predominantly classified into two orders: Planctomycetales and Brocadiales. These gram-negative bacteria exhibit unique features, including division by budding and the presence of stalks or appendages. Their cells are often found in rosette arrangements, and they are notable for possessing an S-layer in their cell envelope, which is relatively uncommon among bacteria. Additionally, Planctomycetes frequently exhibit intracellular...
553